Karyopharm Therapeutics Inc. (KPTI) News
Track canonical SquawkNews coverage tagged to KPTI, Karyopharm Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Karyopharm reports Q2 revenue of $33.4 million, reaffirms 2026 guidance
Karyopharm Therapeutics reported second-quarter revenue of $33.4 million, down from $37.9 million a year earlier, and reaffirmed 2026 revenue guidance of $130 million to $150 million.
EARNINGS | Aug 13, 2026, 12:54 PM UTC
L
Karyopharm Therapeutics affirms FY2026 sales guidance at $130M-$150M
Karyopharm Therapeutics (NASDAQ: KPTI) affirms FY2026 sales guidance of $130.000 million-$150.000 million versus a $133.736 million estimate, keeping the same range.
EARNINGS | Aug 13, 2026, 11:32 AM UTC
L
Karyopharm (KPTI) reports Q2 2026 financial results; myelofibrosis sNDA progress
Karyopharm (KPTI) reports second-quarter 2026 financial results and highlights continued progress toward a myelofibrosis sNDA submission, according to the company’s release.
EARNINGS | Aug 13, 2026, 11:30 AM UTC
H
Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 200 points on Friday. The Dow traded up 0.38% to 52,406.69 while the NASDAQ rose 0.25% to 25,184.43. The S&P 500 also rose, gainin
EARNINGS | Jul 31, 2026, 04:02 PM UTC
H
KPTI Plunges 71% Premarket
KPTI drops 71% premarket
EQUITY | Jul 31, 2026, 12:47 PM UTC
H
KPTI Downgraded to Neutral
KPTI downgraded to Neutral from Buy
EQUITY | Jul 31, 2026, 11:55 AM UTC
H
Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Amazon.com Inc (NASDAQ: AMZN ) rose sharply in pre-market trading after the company posted upbeat financial results for the second quarter. Amazon reported second-quarter revenue of $200.61 billion, beating the
EARNINGS | Jul 31, 2026, 08:50 AM UTC
H
KPTI Plunges 57% After Trial Update
KPTI falls 57% on trial news
EQUITY | Jul 30, 2026, 08:41 PM UTC
H
Karyopharm Therapeutics to request priority review
Karyopharm seeks priority review for selinexor
EQUITY | Jul 30, 2026, 08:29 PM UTC
L
KPTI Karyopharm Therapeutics - to submit snda to FDA in August 2026 for selinexor plus ruxolitinib in myelofibrosis
KPTI Karyopharm Therapeutics - to submit snda to FDA in August 2026 for selinexor plus ruxolitinib in myelofibrosis
REGULATION | Jul 30, 2026, 08:07 PM UTC
L
KPTI KPTI - Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
KPTI KPTI - Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
EQUITY | Jul 30, 2026, 08:06 PM UTC
L
KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARK
KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARKETWATCH.com
EQUITY | Jul 20, 2026, 07:30 PM UTC